OCGN Q1 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+128.9% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$12M-1204.7% margin

Net Income

-$12M-1175.9% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-83.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$22M

Stockholders' Equity

$30M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$443,000	+128.9%
Gross Profit	$1M	-$10M	+110.4%
Operating Income	-$12M	-$18M	+32.3%
Net Income	-$12M	-$17M	+31.2%